Glycemic Control

PLAINSBORO, N.J. and BAGSVÆRD, Denmark, June 6, 2026 Novo Nordisk has announced positive results from a Phase 2 clinical...

PALO ALTO, Calif., May 14, 2026 Glooko, Inc. announced that the U.S. Food and Drug Administration has granted 510(k)...

REDWOOD CITY, Calif., May 01, 2026 Rezolute, Inc. has announced detailed results from its Phase 3 sunRIZE study evaluating...